Elevated high-density lipoprotein cholesterol, not protective in the presence of homocysteinemia

American Journal of Cardiology

Volumn 79, Issue 5, 1997, Pages 705-706

  Superko, H Robert ^a,b  

^a Cholesterol Genet Heart Dis Inst   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHIONINE; PYRIDOXINE;

AGED; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; CORONARY RISK; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; METABOLIC DISORDER; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; HOMOCYSTEINE; HUMANS; INTERMITTENT CLAUDICATION; RISK FACTORS;

EID: 0030945254     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00851-X     Document Type: Article

References (11)

1. Eder HA, Gidez LI. The clinical significance of the plasma high density lipoproteins. Med Clin North Am. 66:1982;431-440.
2. Glueck CJ, Fallat RW, Millett F, Gartside P, Elston RC, Go RCP. Familial hyper-alpha-lipoproteinemia: studies in eighteen kindreds. Metabolism. 24:1975;1243-1265.
3. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. HDL cholesterol and other lipids in coronary heart disease. Circulation. 55:1977;767-772.
4. Myers GL, Cooper GR, Winn CL, Smith SJ. The Center for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements. Clin Lab Med. 9:1989;105-135.
5. Boers GH, Smals AG, Trijbels FJ, Leermakers AI, Kloppenhorg PW. Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years. J Clin Invest. 72:1983;1971-1976.
6. Malinow MR. Hyperhomocysteinemia. A common and easily reversible risk factor for occlusive atherosclerosis. Circulation. 81:1990;2004-2006.
7. von Eckardstein A, Malinow MR, Upson B, Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G. Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men. Arterioscler Thromb. 14:1994;460-464.
8. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb. 13:1993;1327-1333.
9. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscolzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 91:1993;308-318.
10. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 79:1989;1180-1188.
11. Franken DG, Boers GHJ, Blom HJ, Trijbels FJM, Kloppenborg PWC. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb. 14:1994;465-470.